Stocksigma LogoStocksigma Logo

Nestle India Clarifies Reports on FSSAI Legal Action on Baby Formula

Nestle India refuted media reports alleging FSSAI legal action regarding its baby formula products NAN EXCELLA PRO and LACTOGEN PRO on 18th Sep'26

Nestle India Clarifies Reports on FSSAI Legal Action on Baby Formula

Nestle India Ltd 路 Others (Uncategorized) 路 19 Sept 2026, 12:11 am

Nestle India Clarifies Reports on FSSAI Legal Action on Baby Formula Nestle India refuted media reports alleging FSSAI legal action regarding its baby formula products NAN EXCELLA PRO and LACTOGEN PRO on 18th Sep'26, labeling the claims factually incorrect. The company confirmed that both products and their labels were previously approved by FSSAI's expert committee and fully comply with regulatory norms. In response to recent notices, Nestle submitted detailed, scientifically supported justifications for its label declarations. Management confirmed there is zero material impact on operations or financial performance.

Original exchange filing (PDF)

More announcements from Nestle India Ltd

All Nestle India Ltd announcements